SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: July 12, 2002 (Date of earliest event reported:) Moore Medical Corp. -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware 1-8903 22-1897821 -------------------------------------------------------------------------------- (State or other jurisdiction (Commission File (I.R.S. Employer of incorporation) Number) Identification No.) 389 John Downey Drive P.O. Box 1500, New Britain, CT 06050 -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) (860) 826-3600 -------------------------------------------------------------------------------- Registrant's telephone number, including area code -------------------------------------------------------------------------------- (Former name or former address, if changed since last report.) ITEM 5. OTHER EVENTS ------------ A copy of Moore Medical Corp.'s press release, dated July 12, 2002, is attached hereto and also incorporated herein by reference. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS ------------------------------------------------------------------ (c) Exhibits: The following documents are filed as exhibits to this report: 99.1 Press Release of Moore Medical Corp., dated July 12, 2002. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Moore Medical Corp. Date: July 12, 2002 /s/ Linda M. Autore --------------------------------------- Linda M. Autore President and Chief Executive Officer EXHIBIT INDEX 99.1 Press Release of Moore Medical, dated July 12, 2002.